MeMed Severity™

MeMed Severity is a revolutionary test for patients presenting with suspected acute infection or sepsis. It generates a numeric score indicating the likelihood of progressing to severe outcomes.

This device is currently in development and has not been approved for sale by any regulatory authority. The information provided here is for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment.

Sepsis - A global health problem

of all global deaths are
related to sepsis¹

0 %

Readmission rate within 30 days²

0 %

Readmission rate within 30 days²

0 %

Increase in the odds of a poor
outcome for every 1-hour delay in
treatment³

0 %

Increase in the odds of a poor outcome for every 1-hour delay in treatment³

0 %

Average hospitalization cost per patient
when sepsis presented at admission,
$51K in cases of late detection⁴

$ 0 K

Average hospitalization cost per patient when sepsis presented at admission, $51K in cases of late detection⁴

$ 0 K

Increase in EMR sepsis alert during recent years driving alert fatigue⁵

0 %

Increase in EMR sepsis alert during recent years driving alert fatigue⁵

0 %

How It Works

MeMed Severity runs on the MeMed Key®, a cutting edge, compact immunoassay platform that makes it possible to conduct highly sensitive, rapid, multiplexed protein measurements that previously could only be done on large, expensive central lab equipment.

Quick turnaround time (<15 min)

Low sample volume

Easy to Use

Results display

The test categorizes patients into five distinct bins based on the numeric score.

Lower Bins:
Assisting clinicians in making safe discharge decisions, complementing clinical judgment.

Upper Bin: Prompting advanced care, optimizing resource allocation, and improving patient outcomes.

MeMed BV

and MeMed Severity™ Interplay⁶

The paradigm for sepsis management is shifting to a more comprehensive approach. By integrating MeMed BV and MeMed Severity into current workflows and standard of care, clinicians could more accurately assess likelihood of bacterial infections and progression to severe outcomes.

*MeMed BV is intended for use in conjunction with clinical assessments and other laboratory findings as an aid to differentiate bacterial from viral infection.

MeMed Severity™ brings value to care providers,
health systems, and patients

Immediate Risk Assessment

Support triage and evaluation in the Emergency Department (ED), providing crucial information for immediate decision-making.

Short-Term Prognosis

Offer prognostic information within 72 hours, aiding in patient disposition and referral decisions to ensure optimal care pathways.

Disease Monitoring

Potentially guide treatment escalation or de-escalation for hospitalized patients to ensure appropriate care.

Potentially Improve Patient Outcomes

Appropriate supportive care and disposition

Early and informed treatment decisions

Avoid unnecessary interventions and hospitalization

Economical Value

Early detection may reduce complications and treatment costs

Potentially reduce re-admissions, hospital LOS, diagnostic tests and associated burden

Reduce Clinical Burden

Improve resource utilization while minimizing alert fatigue

Aids in increasing ED patient throughput and reduction of ED LOS

Schedule a demo

References

1. Key facts about sepsis. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/sepsis

2. Gadre SK, Shah M, Mireles-Cabodevila E, Patel B, Duggal A. Epidemiology and Predictors of 30-Day Readmission in Patients With Sepsis. Chest. 2019 Mar;155(3):483-490.

3. Seymour CW, Kahn JM, Martin-Gill C, Callaway CW, Yealy DM, Scales D, Angus DC. Delays From First Medical Contact to Antibiotic Administration for Sepsis. Crit Care Med. 2017 May;45(5):759-765

4. Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level. Crit Care Med. 2018 Dec;46(12):1889-1897.

5. Epic’s sepsis algorithm may cause alert fatigue. FIERCE Healthcare. Link

6. Surviving Sepsis Campaign Guidelines 2021. Society of Critical Care Medicine, 2021